Literature DB >> 21160610

Ischemia/reperfusion injury: The role of immune cells.

Mozow Y Zuidema1, Cuihua Zhang.   

Abstract

Ischemia/reperfusion (I/R) injury is an inflammatory condition that is characterized by innate immunity and an adaptive immune response. This review is focused on the acute inflammatory response in I/R injury, and also the adaptive immunological mechanisms in chronic ischemic disease that lead to increased vulnerability during acute events, in relation to the cell types that have been shown to mediate innate immunity to an adaptive immune response in I/R, specifically myocardial infarction. Novel aspects are also highlighted in respect to the mechanisms within the cardiovascular system and cardiovascular risk factors that may be involved in the inflammatory response accompanying myocardial infarction. Experimental myocardial I/R has suggested that immune cells may mediate reperfusion injury. Specifically, monocytes, macrophages, T-cells, mast cells, platelets and endothelial cells are discussed with reference to the complement cascade, toll-like receptors, cytokines, oxidative stress, renin-angiotensin system, and in reference to the microvascular system in the signaling mechanisms of I/R. Finally, the findings of the data summarized in this review are most important for possible translation into clinical cardiology practice and possible avenues for drug development.

Entities:  

Keywords:  Coronary vasculature; Inflammation; Mast cell; Myocardial infarction; T-cell

Year:  2010        PMID: 21160610      PMCID: PMC2999044          DOI: 10.4330/wjc.v2.i10.325

Source DB:  PubMed          Journal:  World J Cardiol


  111 in total

1.  Distinct differentiation potential of blood monocyte subsets in the lung.

Authors:  Limor Landsman; Chen Varol; Steffen Jung
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

Review 2.  Role of blood cells in ischaemia-reperfusion induced endothelial barrier failure.

Authors:  Stephen F Rodrigues; D Neil Granger
Journal:  Cardiovasc Res       Date:  2010-03-17       Impact factor: 10.787

3.  T-cell-mediated lysis of endothelial cells in acute coronary syndromes.

Authors:  Takako Nakajima; Stephanie Schulte; Kenneth J Warrington; Stephen L Kopecky; Robert L Frye; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

Review 4.  Complement inhibitors in myocardial ischemia/reperfusion injury.

Authors:  B R Lucchesi; K S Kilgore
Journal:  Immunopharmacology       Date:  1997-12

5.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival.

Authors:  D Orlic; J Kajstura; S Chimenti; F Limana; I Jakoniuk; F Quaini; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

6.  Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion.

Authors:  N G Frangogiannis; M L Lindsey; L H Michael; K A Youker; R B Bressler; L H Mendoza; R N Spengler; C W Smith; M L Entman
Journal:  Circulation       Date:  1998-08-18       Impact factor: 29.690

Review 7.  Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection.

Authors:  Narci C Teoh; Geoffrey C Farrell
Journal:  J Gastroenterol Hepatol       Date:  2003-08       Impact factor: 4.029

Review 8.  Current progress in the understanding of and therapeutic strategies for ischemia and reperfusion injury of the liver.

Authors:  Shigeki Arii; Kennichi Teramoto; Toru Kawamura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2003

Review 9.  Post-infarct remodelling: contribution of wound healing and inflammation.

Authors:  Stefan Frantz; Johann Bauersachs; Georg Ertl
Journal:  Cardiovasc Res       Date:  2008-10-31       Impact factor: 10.787

10.  Mast cells can secrete vascular permeability factor/ vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression.

Authors:  J Boesiger; M Tsai; M Maurer; M Yamaguchi; L F Brown; K P Claffey; H F Dvorak; S J Galli
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

View more
  25 in total

1.  Methods of cell purification: a critical juncture for laboratory research and translational science.

Authors:  Peter J Amos; Esra Cagavi Bozkulak; Yibing Qyang
Journal:  Cells Tissues Organs       Date:  2011-10-12       Impact factor: 2.481

2.  Age-associated differences in gene expression in response to delayed anesthetic preconditioning.

Authors:  C Zhong; N Fleming; X Lu; P Moore; H Liu
Journal:  Age (Dordr)       Date:  2011-10-19

3.  Bifidobacterium animalis subsp. lactis 420 mitigates the pathological impact of myocardial infarction in the mouse.

Authors:  C A Danilo; E Constantopoulos; L A McKee; H Chen; J A Regan; Y Lipovka; S Lahtinen; L K Stenman; T-V V Nguyen; K P Doyle; M J Slepian; Z I Khalpey; J P Konhilas
Journal:  Benef Microbes       Date:  2017-04-14       Impact factor: 4.205

Review 4.  Immunohistochemical detection of early myocardial infarction: a systematic review.

Authors:  Cristina Mondello; Luigi Cardia; Elvira Ventura-Spagnolo
Journal:  Int J Legal Med       Date:  2016-11-25       Impact factor: 2.686

5.  Inflammation and reactive oxygen species in cardiovascular disease.

Authors:  Nannan Zhang; Bradley T Andresen; Cuihua Zhang
Journal:  World J Cardiol       Date:  2010-12-26

Review 6.  Matrix metalloproteinases: drug targets for myocardial infarction.

Authors:  Andriy Yabluchanskiy; Yaojun Li; Robert J Chilton; Merry L Lindsey
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

7.  Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models.

Authors:  Yasuhiro Ogura; Noriyuki Ouchi; Koji Ohashi; Rei Shibata; Yoshiyuki Kataoka; Takahiro Kambara; Tetsutaro Kito; Sonomi Maruyama; Daisuke Yuasa; Kazuhiro Matsuo; Takashi Enomoto; Yusuke Uemura; Megumi Miyabe; Masakazu Ishii; Takashi Yamamoto; Yuuki Shimizu; Kenneth Walsh; Toyoaki Murohara
Journal:  Circulation       Date:  2012-08-28       Impact factor: 29.690

Review 8.  The role of mast cells in ischemia and reperfusion injury.

Authors:  Mu-qing Yang; Yuan-yuan Ma; Jing Ding; Ji-yu Li
Journal:  Inflamm Res       Date:  2014-08-10       Impact factor: 4.575

9.  Lactobacillus reuteri attenuates cardiac injury without lowering cholesterol in low-density lipoprotein receptor-deficient mice fed standard chow.

Authors:  Matthew Perry Koppinger; Marissa Anne Lopez-Pier; Rinku Skaria; Preston Royal Harris; John P Konhilas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-05-15       Impact factor: 4.733

Review 10.  Mesenchymal Stem Cell Transplantation for Ischemic Diseases: Mechanisms and Challenges.

Authors:  Thi-Tuong Van Nguyen; Ngoc Bich Vu; Phuc Van Pham
Journal:  Tissue Eng Regen Med       Date:  2021-04-21       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.